CrushSCI.com
Journal Selection & Manuscript Polishing Services
Immunotherapy journal cover Medicine
Back to journal directory

Review Cycle Records

Immunotherapy

Taylor & Francis SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q3
143.2Average days
133Median days
43Fastest days
257Longest days
1352025 publications

Paper Review Records

All Paper Review Records

14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

182 days

Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer

AuthorsAlfredo Tartarone; Raffaele Conca; Alessandra Perrone; Rosa Lerose

Affiliations1. IRCCS-CROB Referral Cancer Center of Basilicata

Source PDF DOI Publisher page
137 days

Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectives

AuthorsAditya Raj; Zuber Khan; Mumtaz; Sidharth Mehan; Tapan Lamba; Niyati Pandoh; Keerti Dayal

Affiliations1. ISF College of Pharmacy (An Autonomous College); 2. ISF College of Pharmacy (Affiliated to IK Gujral Punjab Technical University, Jalandhar); 3. School of Pharmaceutical Education and Research

Source PDF DOI Publisher page
128 days

The role of artificial intelligence in predicting immunotherapy treatment outcomes based on gut microbiota composition in cancer patients: a meta-analysis

AuthorsLeen Alhassan; Bassel Alrabadi; Suhel F. Batarseh; Yousef Alghzawi; Natalie Bandak; Aseel Badwan; Hadeel Al kayed

Affiliations1. Jordan University of Science and Technology; 2. University of Jordan; 3. WellStar Cobb Hospital

Source PDF DOI Publisher page
65 days

Making dietary modification in the immunotherapy Era: from mechanistic evidence to practical implementation

AuthorsParham Habibzadeh; Drew Hurd; Diwakar Davar

Affiliations1. University of Pittsburgh Medical Center; 2. University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center; 3. University of Pittsburgh

Source PDF DOI Publisher page
129 days

Cost-effectiveness analysis of Nivolumab plus Ipilimumab versus Nivolumab monotherapy in previously treated metastatic colorectal cancer patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) in China

AuthorsXiaohong Zhu; Xu Yang; Tong Liu

Affiliations1. Harbin Medical University Cancer Hospital

Source PDF DOI Publisher page
43 days

Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiency

AuthorsRoberto Crea; Elena Perez; Chaim M. Roifman

Affiliations1. Kedrion S.p.A; 2. Allergy Associates of the Palm Beaches; 3. Hospital for Sick Children

Source PDF DOI Publisher page
257 days

Impact of sublingual immunotherapy with dust mite drops on ECP, TARC, VCAM-1 inflammatory status in patients with allergic rhinitis

AuthorsBangyu Deng; Yunxia Zhao; Jisheng Liu

Affiliations1. The Affiliated Suzhou Hospital of Nanjing Medical University; 2. Suzhou Jinji Lake Health Service Center; 3. The First Affiliated Hospital of Soochow University

Source PDF DOI Publisher page
91 days

Lupus nephritis treatment: a comprehensive overview of recent meta-analyses and future directions

AuthorsFeigao Li; Xizhe Liu; Bokun Chen; Menghao Li; Xiuju Liu

Affiliations1. The Second Hospital of Hebei Medical University; 2. The Third Hospital of Hebei Medical University; 3. Hebei Medical University

Source PDF DOI Publisher page
199 days

Modified Dendritic cells as a therapeutic platform in hematologic malignancies with translational insights from central nervous system tumors

AuthorsMahsa Akbari Oryani; Hossein Tabarsa; Ghazaleh Hatamian; Mahboubeh Tajaldini; Hossein Javid; Ali Mehri; Mehdi Karimi-Shahri

Affiliations1. Mashhad University of Medical Sciences; 2. Mazandaran University of Medical Sciences; 3. Shahid Beheshti University; 4. Golestan University of Medical Sciences; 5. Varastegan Institute for Medical Sciences; 6. Gonabad University of Medical Sciences

Source PDF DOI Publisher page
201 days

The long-term effectiveness of specific immunotherapy in cat allergy: a real-life study

AuthorsNilay Orak Akbay; Dilşad Mungan; Betül Ayşe Sin

Affiliations1. Ankara Etlik City Hospital; 2. Ankara University School of Medicine

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.